Phase 2
๐ Investigational Drug / Biologic
NCT07432958
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
๐ University of Arkansas for Medical Sciences (Site #208) โ Little Rock, Arkansas
View Study & Screener โ